December 17, 2024 - 16:03

President-elect Trump has publicly defended his decision to appoint Robert F. Kennedy Jr. as the new secretary of health and human services. During his first news conference following the election, Trump faced questions regarding Kennedy's controversial stance on vaccines. In response, he expressed confidence in Kennedy's approach, stating, "I think he's going to be much less radical than you would think."
Kennedy, known for his vocal skepticism about vaccine safety, has sparked debate among health officials and the public alike. However, Trump emphasized that Kennedy’s expertise and experience in public health would be beneficial in addressing the nation’s health challenges. The president-elect's remarks suggest a belief that Kennedy's perspective could lead to a more balanced dialogue on health policies.
As the new administration prepares to take office, the appointment has raised eyebrows, but Trump remains steadfast in his choice, asserting that Kennedy's leadership will foster a constructive approach to health issues in the country.
November 28, 2025 - 22:10
Mustaches for Mental Health: Movember's Campaign Gains TractionIn a unique and engaging approach to raise awareness about men`s mental and physical health, the Movember Research Institute is spearheading an initiative that combines facial hair with important...
November 28, 2025 - 05:53
Dolly Parton Spreads Thanksgiving Cheer Despite Recent Health StrugglesDolly Parton wished fans a Happy Thanksgiving in a heartfelt video shared on her Instagram page on Thursday, November 27. The beloved country music icon, who has faced health challenges recently,...
November 27, 2025 - 14:32
Tensions Rise Over ACA Tax Subsidies for Millions of AmericansThe clock is ticking for the 22 million Americans currently enrolled in the Affordable Care Act (ACA), as lawmakers remain divided over the extension of ACA tax subsidies. Many individuals and...
November 26, 2025 - 22:38
Medicare Secures Significant Price Reductions on 15 Essential MedicationsMedicare has successfully negotiated lower prices for 15 crucial medications following a second round of discussions with pharmaceutical companies. Among the notable drugs included in this...